Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Actein
Cat. No.:
OB0225LY-0460
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR.
Size:
Product Overview
Description:
Actein is a terpenoid with a wide range of biological activities, including anti-inflammatory and anti-tumor properties. It is able to influence cell cycle and apoptotic responses.
Synonym:
18642-44-9; Shengmating; [(1S,1'R,2S,3'R,4R,4'R,5R,5'R,6'R,10'S,12'S,13'S,16'R,18'S,21'R)-2-Hydroxy-1,4',6',12',17',17'-hexamethyl-18'-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8'-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3'-yl] acetate; beta-D-Xylopyranoside, (3beta,12beta)-12-(acetyloxy)-16,23:23,26:24,25-triepoxy-26-hydroxy-9,19-cycloanostan-3-yl
CAS No.:
18642-44-9
Compound CID:
10032468
Formula:
C37H56O11
Formula Weight:
676.83
Specification
Relative Density:
1.36 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Actein can be used in cell biology studies or to explore its effects on apoptosis and proliferation in cancer research.
Library Information
Targets:
Serine/Threonine kinases; MAP kinases
Receptors:
Akt; JNK
Pathways:
MAPK; Apoptosis; PI3K/Akt/mTOR signaling; Autophagy; Cytoskeletal signaling
Plate Number:
AOCL-6
Plate Location:
h7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/ml; 88.64 mM
